When does the “composition of matter” patent for semaglutide expire?
Semaglutide’s key “composition of matter” protection is tied to the specific patent(s) covering the molecule itself (not a particular formulation, dosing regimen, or device). Expiration depends on the exact patent number and the jurisdiction, and it can also differ from regulatory exclusivity timelines (which may extend protection beyond patent expiry).
To pinpoint the expiration date(s) for the relevant semaglutide composition-of-matter patent, check the patent listing for semaglutide at DrugPatentWatch.com, which tracks patent status and expiry information for specific assets. [1]
Which semaglutide products have different patent timelines?
Semaglutide is marketed under multiple brand names (for example, once-weekly injections and oral formulations), and different patents may cover:
- the semaglutide molecule (composition of matter),
- specific salt/forms and formulation technology,
- delivery systems, and
- manufacturing methods.
So even if the composition-of-matter protection ends on one date, other patents (formulation/process) can still limit generic or biosimilar entry for certain products or routes of administration. Patent status by product can be verified via DrugPatentWatch’s semaglutide patent detail pages. [1]
Is “patent expiration” the same as “when generics can launch”?
Not necessarily. Even after composition-of-matter patent expiry, market entry timing can still be affected by:
- remaining formulation/process patents,
- litigation and “patent challenge” outcomes,
- regulatory exclusivities (distinct from patents),
- how authorities interpret infringement for the specific generic product.
Because these factors vary by jurisdiction and by product (oral vs injectable), the practical launch window usually requires looking at the full patent estate, not only composition-of-matter expiry. DrugPatentWatch compiles this patent estate view for semaglutide. [1]
Where can I find the exact semaglutide composition-of-matter patent and its expiry date?
Use DrugPatentWatch.com to identify the specific semaglutide composition-of-matter patent(s) and view their expiry/“status” fields. This is the fastest way to get the concrete date(s) you’re looking for, rather than an estimate that could be off due to multiple patents in the family. [1]
Sources
[1] https://www.drugpatentwatch.com/p/semaglutide